Esr1 Y537 mutations are associated with increased baseline circulating tumor cells enumeration for patients with estrogen receptor positive metastatic breast cancer

被引：0
|
作者：
Zhang, Qiang
Jiao, Jianhua
D'Amico, Paolo
Davis, Andrew A.
Qin, Weijun
Gerratana, Lorenzo
Jacob, Saya L.
Zhang, Youbin
Donahue, Jeannine
Qiang, Wenan
Shah, Ami N.
Flaum, Lisa
Gradishar, William
Platanias, Leonidas C.
Cristofanilli, Massimo
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-01-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-01-08
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Identification of ESR1 splice variants associated with prognosis in estrogen receptor positive breast cancer
    Lee, H-B
    Han, W.
    Ko, S.
    Kim, M-S
    Lim, S.
    Lee, K-M
    Kang, Y. J.
    Han, J. H.
    Kim, Y.
    Yoo, T-K
    Moon, H-G
    Noh, D-Y
    Kim, S.
    Han, W.
    CANCER RESEARCH, 2016, 76
  • [22] Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer
    Kinslow, Connor J.
    Tang, Ashley
    Chaudhary, Kunal R.
    Cheng, Simon K.
    JNCI CANCER SPECTRUM, 2022, 6 (05)
  • [23] Detection of ESR1 Mutations Based on Liquid Biopsy in Estrogen Receptor-Positive Metastatic Breast Cancer: Clinical Impacts and Prospects
    Liao, Hao
    Huang, Wenfa
    Pei, Wendi
    Li, Huiping
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [24] Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis
    Zhang, Kai
    Hong, Ruoxi
    Xu, Fei
    Xia, Wen
    Kaping, Lee
    Qin, Ge
    Zheng, Qiufan
    Lu, Qianyi
    Shi, Yan Xia
    Yuan, Zhong Yu
    Wang, Shusen
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 2573 - 2580
  • [25] Estrogen-Receptor Loss and ESR1 Mutation in Estrogen-Receptor-Positive Metastatic Breast Cancer and the Effect on Overall Survival
    Westenend, Pieter J.
    Meurs, Claudia J. C.
    de Leeuw, Bertie
    Akkers, Robert C.
    CANCERS, 2024, 16 (17)
  • [26] Implications of ESR1 Mutations in Hormone Receptor-Positive Breast Cancer
    Tomás Reinert
    Rodrigo Gonçalves
    José Bines
    Current Treatment Options in Oncology, 2018, 19
  • [27] Implications of ESR1 Mutations in Hormone Receptor-Positive Breast Cancer
    Reinert, Tomas
    Goncalves, Rodrigo
    Bines, Jose
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (05)
  • [28] Association of ESR1 Mutations and Visceral Metastasis in Patients with Estrogen Receptor-Positive Advanced Breast Cancer from Brazil
    Reinert, Tomas
    Coelho, Guilherme Portela
    Mandelli, Jovana
    Zimermann, Edineia
    Zaffaroni, Facundo
    Bines, Jose
    Barrios, Carlos Henrique
    Graudenz, Marcia Silveira
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [29] Clinical significance of sequential measurements of ESR1 mutations in plasma cell-free DNA in estrogen receptor positive recurrent metastatic breast cancer patients
    Takeshita, T.
    Yamamoto, Y.
    Yamamoto-Ibusuki, M.
    Sueta, A.
    Tomiguchi, M.
    Iwase, H.
    CANCER RESEARCH, 2017, 77
  • [30] ESR1 methylation in circulating tumor cells, ctDNA and primary tumors of breast cancer patients
    Mastoraki, Sophia
    Strati, Areti
    Tzanikou, Eleni
    Politaki, Eleni
    Koutsodontis, George
    Kaklamanis, Loukas
    Malamos, Nikolaos
    Psyrri, Amanda
    Georgoulias, Vassilis
    Lianidou, Evi
    CANCER RESEARCH, 2017, 77
12345